Your Urgent Update On The Latest Influ Gonewild Developments
The U.S. Food and Drug Administration announced recently that it will not review Moderna's mRNA CNN correspondent Ivan Rodriguez spoke with a public health professor about this decision.
FDA to review Moderna's new mRNA flu vaccine
CNN correspondent Ivan Rodriguez spoke with a public health professor about this decision.